In quantitative double‑antibody sandwich ELISA systems, the hook effect (high‑dose hook effect, prozone phenomenon) is a deceptive analytical interference. It does not stem from operational errors or kit defects, but represents an intrinsic immune reaction feature caused by stoichiometric imbalance between antigen and antibody. Serial sample dilution pre‑experiment is currently the most direct and universal laboratory method to identify, verify and avoid the hook effect.

Biotin - the core value of the biotin-avidin system lies in its ability to build a stable and universal signal amplification bridge through the unique tetravalent high-affinity interaction between biotin and streptavidin, without interfering with antigen-antibody specific recognition. BAS-ELISA is a mature approach that combines this amplification system with solid-phase enzyme-linked immunosorbent assay. It balances sensitivity, reproducibility, and development cost, making it the mainstream choice for the development of low-abundance protein quantification kits.

Conducting preliminary experiments before formal batch testing with enzyme-linked immunosorbent assay (ELISA) is a key method to avoid problems such as sample concentrations exceeding the quantification range, matrix interference, excessive well-to-well variation, and waste of precious samples.

After obtaining raw OD readings from ELISA assays, standard‑curve fitting and sample concentration conversion are critical to the reliability of experimental data.

This article will use Curve Expert software to complete, step by step, data import, standard curve plotting, fit evaluation, and the calculation of concentrations of the samples to be tested.

This document compiles frequently‑asked questions on data processing, standard curve fitting, anomaly troubleshooting, result interpretation and reporting specifications for quantitative and qualitative ELISA assays. It follows practical laboratory standards, supports beginners and experimental review, unifies criteria for data processing and result judgment, and helps avoid common experimental errors and misinterpretations.

In ELISA experiments, many researchers confuse qualitative ELISA with quantitative ELISA, leading to improper kit selection, result interpretation bias and redundant workflows. Though both are based on the core principle of antigen‑antibody specific binding, they differ significantly in experimental purpose, workflow, output format and application scenarios. This document compiles frequently‑asked questions from scientific research, clinical testing and inspection industries to address core concerns of qualitative and quantitative ELISA.

ELISA is the most commonly used quantitative detection technique in biological experiments and clinical testing. The accuracy and reproducibility of experimental results highly depend on standardized sample addition procedures and controlled incubation conditions. Most issues in ELISA experiments, such as false positives, false negatives, numerical deviations, and large inter-well differences, are not due to reagent quality but result from improper control of three core details: temperature, time, and light protection.

ELISA blocking is a crucial step in the enzyme-linked immunosorbent assay, and the effectiveness of blocking directly determines the experimental background, signal-to-noise ratio, and the reliability of the final data. In practical experiments, many people encounter various issues in selecting the blocking solution, setting incubation conditions, and troubleshooting abnormal results.

ELISA is a fundamental immunoassay technique widely used in biological experiments, scientific research testing and clinical laboratory diagnosis. Beginners often get confused about its principles, workflows, classifications, detection range and other basic concepts. This article organizes core ELISA knowledge in a FAQ format to cover common blind spots and help novice researchers quickly master key points of ELISA.